tetano
Editor, Senior Moderator
Cureus
. 2021 Dec 9;13(12):e20292.
doi: 10.7759/cureus.20292. eCollection 2021 Dec.
Post-COVID-19 Vaccine Parosmia: A Case Report
Osama S Zamzami[SUP] 1 [/SUP], Abdulrahman F Kabli[SUP] 1 [/SUP], Ammar S Alhothali[SUP] 1 [/SUP], Omar S Alhothali[SUP] 1 [/SUP], Tayil A Alharbi[SUP] 1 [/SUP], Abdullah K Bahakim[SUP] 1 [/SUP], Osama A Marglani[SUP] 2 [/SUP]
Affiliations
Abstract
We present the case of a healthy 38-year-old male who developed parosmia following a second dose of AstraZeneca with a negative nasal swab of coronavirus disease 2019 (COVID-19) infection. The patient noted parosmia that started suddenly after one week of receiving the second dose of AstraZeneca with no association with other symptoms. The patient has still not recovered from his parosmia until the publication of this article. The olfactory disorder was confirmed using a validated questionnaire for parosmia assessment and examination by rhinoscopy. Parosmia is a rare side effect of COVID-19, and its pathophysiological mechanism is still unknown. More research in the future is needed to know the association of parosmia with COVID-19 vaccine.
Keywords: astrazeneca; covid-19; olfactory dysfunction; parosmia; vaccine.
. 2021 Dec 9;13(12):e20292.
doi: 10.7759/cureus.20292. eCollection 2021 Dec.
Post-COVID-19 Vaccine Parosmia: A Case Report
Osama S Zamzami[SUP] 1 [/SUP], Abdulrahman F Kabli[SUP] 1 [/SUP], Ammar S Alhothali[SUP] 1 [/SUP], Omar S Alhothali[SUP] 1 [/SUP], Tayil A Alharbi[SUP] 1 [/SUP], Abdullah K Bahakim[SUP] 1 [/SUP], Osama A Marglani[SUP] 2 [/SUP]
Affiliations
- PMID: 35028203
- PMCID: PMC8747983
- DOI: 10.7759/cureus.20292
Abstract
We present the case of a healthy 38-year-old male who developed parosmia following a second dose of AstraZeneca with a negative nasal swab of coronavirus disease 2019 (COVID-19) infection. The patient noted parosmia that started suddenly after one week of receiving the second dose of AstraZeneca with no association with other symptoms. The patient has still not recovered from his parosmia until the publication of this article. The olfactory disorder was confirmed using a validated questionnaire for parosmia assessment and examination by rhinoscopy. Parosmia is a rare side effect of COVID-19, and its pathophysiological mechanism is still unknown. More research in the future is needed to know the association of parosmia with COVID-19 vaccine.
Keywords: astrazeneca; covid-19; olfactory dysfunction; parosmia; vaccine.